Nusano Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
133
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$115M
- Investors
-
5
Nusano General Information
Description
Developer of a current ion source and linear accelerator intended to remove the current limitations of radioisotope manufacturing for medical application and innovation. The company offers a broad range of diagnostic and therapeutic radioisotopes which are produced uranium-free, helping healthcare sector clients develop radiopharmaceuticals for personalized cancer therapies at comparatively lower costs.
Contact Information
Website
www.nusano.comCorporate Office
- 28575 Livington Avenue
- Valencia
- Santa Clarita, CA 91355
- United States
Corporate Office
- 28575 Livington Avenue
- Valencia
- Santa Clarita, CA 91355
- United States
Nusano Timeline
Nusano Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series C) | 01-Oct-2024 | $115M | Completed | Generating Revenue | ||
4. Later Stage VC (Series B) | 03-Nov-2022 | Completed | Generating Revenue | |||
3. Later Stage VC (Series B) | 23-Sep-2021 | Completed | Generating Revenue | |||
2. Later Stage VC (Series A) | 24-Oct-2018 | $41.5M | $44.7M | Completed | Generating Revenue | |
1. Seed Round | 06-Nov-2017 | $3.19M | $3.19M | Completed | Generating Revenue |
Nusano Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B+ | ||||||||
Series B | ||||||||
Series A | 42,811,907 | $0.000010 | 8% | $0.97 | $0.97 | 1x | $0.97 | 30.77% |
Nusano Patents
Nusano Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-9659736-B2 | Particle beam isotope generator apparatus, system and method | Active | 15-May-2009 | ||
US-20150228438-A1 | Particle beam isotope generator apparatus, system and method | Active | 15-May-2009 | ||
US-20100290575-A1 | Particle beam isotope generator apparatus, system and method | Inactive | 15-May-2009 | ||
AU-2009346233-A1 | Ecr particle beam source apparatus, system and method | Active | 15-May-2009 | ||
EP-2430637-A1 | Ecr particle beam source apparatus, system and method | Inactive | 15-May-2009 | G21C17/112 |
Nusano Signals
Nusano Investors (5)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Wasatch Equity Partners | PE/Buyout | Minority | ||
BrightEdge | Impact Investing | Minority | ||
Casdin Capital | Venture Capital | Minority | ||
Verily Life Sciences | PE-Backed Company | Minority | ||
S32 | Venture Capital | Minority |
Nusano FAQs
-
When was Nusano founded?
Nusano was founded in 2016.
-
Where is Nusano headquartered?
Nusano is headquartered in Santa Clarita, CA.
-
What is the size of Nusano?
Nusano has 133 total employees.
-
What industry is Nusano in?
Nusano’s primary industry is Diagnostic Equipment.
-
Is Nusano a private or public company?
Nusano is a Private company.
-
What is Nusano’s current revenue?
The current revenue for Nusano is
. -
How much funding has Nusano raised over time?
Nusano has raised $218M.
-
Who are Nusano’s investors?
Wasatch Equity Partners, BrightEdge, Casdin Capital, Verily Life Sciences, and S32 have invested in Nusano.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »